|
|
|
The Wisconsin Alumni Research Foundation and the Geron Corporation announced today that they had reached a patent licensing agreement that is expected to make it easier for other companies and academic scientists to develop medical treatments using human embryonic stem cells. The agreement settles a lawsuit between them and narrows the exclusive commercial rights that Geron has to embryonic stem cells.
Full story published in the New York Times, Jan 10, 2002.
Message posted by: Anthony W.I. Lo
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|